Let the news flow begin , we should receive the NOM shortly as they have to give 4 weeks notice. They will have some good ANN's coming IMO to get this over the line.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling